A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

NCT03276598 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

233

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Pharmacogenetics

Interventions

DRUG: Amlodipine
DRUG: Bisoprolol
DRUG: Hydrochlorothiazide
DRUG: Losartan
DRUG: Placebo

Sponsor

Helsinki University Central Hospital